Page last updated: 2024-08-21

oxazoles and Diabetic Angiopathies

oxazoles has been researched along with Diabetic Angiopathies in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buse, JB; Grobbee, DE; Henry, RR; Lincoff, AM; Malmberg, K; Mellbin, L; Neal, B; Nicholls, SJ; Nozza, A; Rydén, L; Schrieks, IC; Schwartz, GG; Stähli, BE; Svensson, A; Tardif, JC; Wedel, H; Weichert, A1
Wilding, JP1
Farkouh, M; Plutzky, J; Rosenson, RS; Wright, RS1
Reid, JL1
Bauduceau, B; Dupuy, O; Mayaudon, H1

Reviews

4 review(s) available for oxazoles and Diabetic Angiopathies

ArticleYear
PPAR agonists for the treatment of cardiovascular disease in patients with diabetes.
    Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:11

    Topics: Blood Glucose; Cardiovascular Diseases; Clinical Trials, Phase II as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dyslipidemias; Humans; Hypoglycemic Agents; Oxazoles; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones; Thiophenes; Treatment Outcome

2012
Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects.
    American heart journal, 2012, Volume: 164, Issue:5

    Topics: Alkanesulfonates; Diabetic Angiopathies; Glycine; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Oxazines; Oxazoles; Phenylpropionates; Phosphorylation; PPAR alpha; PPAR delta; PPAR gamma; Thiazolidinediones; Thiophenes; United States; United States Food and Drug Administration

2012
Rilmenidine: a clinical overview.
    American journal of hypertension, 2000, Volume: 13, Issue:6 Pt 2

    Topics: Albuminuria; Animals; Antihypertensive Agents; Diabetic Angiopathies; Humans; Hyperlipidemias; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Oxazoles; Rilmenidine; Treatment Outcome

2000
Efficacy of rilmenidine, a selective I1 imidazoline receptor binding agent in diabetic hypertensive patients.
    American journal of hypertension, 2000, Volume: 13, Issue:6 Pt 2

    Topics: Antihypertensive Agents; Clinical Trials as Topic; Diabetic Angiopathies; Humans; Hypertension; Imidazoline Receptors; Oxazoles; Receptors, Drug; Rilmenidine

2000

Trials

1 trial(s) available for oxazoles and Diabetic Angiopathies

ArticleYear
Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.
    Diabetes care, 2018, Volume: 41, Issue:8

    Topics: Acute Coronary Syndrome; Adiponectin; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fatty Acids, Nonesterified; Female; Humans; Male; Middle Aged; Myocardial Infarction; Oxazoles; Retrospective Studies; Stroke; Thiophenes; Treatment Outcome

2018
chemdatabank.com